CAP:EURONEXT PARISCapgemini SE Analysis
Data as of 2026-05-29 - not real-time
$9.26
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Rithm Capital Corp. (CAP) is trading at $9.26, well below its 20‑day ($9.46) and 50‑day ($9.59) simple moving averages, signaling a short‑term bearish bias. The stock sits above a firm support around $8.93 but remains under the near‑term resistance of $9.95, while the MACD histogram is negative and the RSI hovers near 40, suggesting limited upside momentum. Fundamentally, the company appears markedly cheap – a trailing P/E of 8.5 versus an industry average of 32.6 and a price‑to‑book of 0.74 – and it offers an eye‑catching dividend yield of 10.8% with a payout ratio near 92%. However, the balance sheet is heavily strained, with debt exceeding $40 billion, a debt‑to‑equity ratio over 400, and negative operating cash flow, raising doubts about the sustainability of that dividend.
The high 30‑day volatility (≈23%) and a max drawdown of over 30% underscore the stock’s risk profile, yet analyst consensus leans strongly bullish (median target $13.5) and the upside/downside projection exceeds 45%. If the firm can stabilize cash generation and manage its leverage, the valuation gap and robust revenue growth (≈65% YoY) could translate into substantial medium‑ to long‑term gains.
The high 30‑day volatility (≈23%) and a max drawdown of over 30% underscore the stock’s risk profile, yet analyst consensus leans strongly bullish (median target $13.5) and the upside/downside projection exceeds 45%. If the firm can stabilize cash generation and manage its leverage, the valuation gap and robust revenue growth (≈65% YoY) could translate into substantial medium‑ to long‑term gains.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below 20‑day and 50‑day SMAs
- Bearish MACD and neutral RSI
- Elevated short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Significant valuation discount to peers
- Strong revenue growth and high dividend yield
- Outstanding debt load and negative cash flow
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low P/E and P/B relative to industry
- Projected upside of ~47% versus current price
- Potential for cash‑flow improvement and debt reduction
Key Metrics & Analysis
Financial Health
Revenue Growth64.60%
Profit Margin17.00%
P/E Ratio8.5
ROE8.46%
ROA1.51%
Debt/Equity422.94
P/B Ratio0.7
Op. Cash Flow$-2612631040
Industry P/E32.6
Technical Analysis
TrendBearish
RSI40.4
Support$8.93
Resistance$9.95
MA 20$9.46
MA 50$9.59
MA 200$10.81
MACDBearish
VolumeStable
Fear & Greed Index93.23
Valuation
Target Price$13.61
Upside/Downside46.99%
GradeUndervalued
TypeBlend
Dividend Yield10.80%
Risk Assessment
Beta0.82
Volatility23.01%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.